DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
C•••••• C••••••• R•••••••• I••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Mar 31, 2025sponsor unattributed
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
101¢ · 100¢ · 100¢ · 100¢ · 100¢Q4 2023 to Q1 2025
Principal held
at least $5.8M
sum of BDC pieces, a lower bound
Fair value
$5.8M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Nov 8, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2023
latest Mar 31, 2025
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Mar 31, 2025, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| B•• I••••••••• C••• | $5.76M | 100¢ | 0 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B•• I••••••••• C••• | term loan first lien F•••• L•••/S••••• S•••••• D••• I••••••• R••• 10.19% R•••••••• R••• and S••••• S••• + 5.75% | $5.8M | $5.8M 100c | SOFR+575 bp |
Capital structure as the BDCs see it
latest quarter end Mar 31, 2025
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Mar 31, 2025 | at least $5.8M | 100c | SOFR+575 bp | Nov 8, 2028 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2025 | 1 | $5.8M | $5.8M | 100c | 0 |
| Dec 31, 2024 | 1 | $11.5M | $11.5M | 100c | 0 |
| Sep 30, 2024 | 1 | $5.8M | $5.8M | 100c | 0 |
| Jun 30, 2024 | 1 | $5.8M | $5.8M | 100c | 0 |
All 5 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2023 | 1 | $5.8M | $5.8M | 101c | 0 |
What changed
- Facility left every BDC scheduleMar 31, 2025
- Maturity extended (observed)Dec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- New borrower on a BDC scheduleDec 31, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- C•••••• C••••••• R•••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it